GABRIEL ARCHER: Open Payments
NPI 1245950153 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 11 payments from 5 companies in 2025. Trend: 2023 $155 · 2024 $360 · 2025 $429
Food & beverage: $420Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $135 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, Auvelity, Kerendia, GVOKE HYPOPEN.
Industry payments across VA — which companies pay providers there.
